Mangoceuticals (MGRX) Treasury Shares (2022 - 2024)

Mangoceuticals has disclosed Treasury Shares across 3 years of filings, most recently posting $1.4 million for Q1 2024.

• Treasury Shares for Q1 2024 came in at $1.4 million, up 10.8% year-over-year; the trailing twelve-month figure through Mar 2024 was $1.4 million (up 10.8% YoY), and the FY2023 annual result was $1.3 million, down 32.85% from the prior year.
• Treasury Shares came in at $1.4 million for Q1 2024 at Mangoceuticals, up from $1.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.0 million in Q4 2022 to a low of -$992134.0 in Q3 2023.
• The 3-year median for Treasury Shares is $1.3 million (2023), against an average of $1.0 million.
• Across the five-year window, Treasury Shares plunged 32.85% in 2023 and increased 10.8% in 2024, its largest moves.
• Mangoceuticals' Treasury Shares stood at $2.0 million in 2022, then slumped by 32.85% to $1.3 million in 2023, then increased by 3.13% to $1.4 million in 2024.
• The last three Treasury Shares figures came in at $1.4 million (Q1 2024), $1.3 million (Q4 2023), and -$992134.0 (Q3 2023), per Business Quant data.